Clinical Trial Update: Prevention of Asthma Relapse After Discharge From Emergency [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing prevention of asthma relapse after emergency department discharge has completed (sponsor AstraZeneca).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED